Analysis in this study showed that interleukin-6 (IL-6) levels in the cerebrospinal fluid of patients diagnosed with de novo multiple sclerosis (MS) were significantly higher compared to the healthy population. The gene discussed is IL6; the disease is myeloid sarcoma.